Niagen Bioscience Inc

NASDAQ: NAGE · Real-Time Price · USD
10.01
0.30 (3.09%)
At close: Aug 15, 2025, 3:59 PM
10.05
0.40%
After-hours: Aug 15, 2025, 07:52 PM EDT

Niagen Bioscience Inc Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
31.12M 30.48M 29.13M 25.58M 22.74M 22.15M 21.2M 19.5M 20.32M 22.56M 21M 17.06M 16.73M 17.26M 17.76M 17.31M 17.7M 14.68M
Cost of Revenue
10.89M 11.15M 10.93M 9.34M 9.05M 8.7M 8.26M 7.53M 7.97M 9.04M 8.98M 6.86M 6.69M 6.73M 6.89M 6.73M 6.89M 5.45M
Gross Profit
20.23M 19.33M 18.2M 16.24M 13.69M 13.46M 12.94M 11.97M 12.36M 13.52M 12.02M 10.21M 10.04M 10.53M 10.87M 10.58M 10.81M 9.23M
Operating Income
3.19M 4.77M 7.11M 1.6M -256K -731K -168K -1.15M -2.32M -1.97M -1.44M -3.06M -6.39M -7.73M -5.32M -8.84M -5.55M -7.36M
Interest Income
552K 459K 373K 276K 241K 239K 282K 188K 125K 66K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
3.74M 5.23M 7.48M 1.88M -15K -492K 114K -959K -2.19M -1.9M -1.42M -985K -6.4M -7.74M -5.33M -8.86M -5.57M -7.38M
Net Income
3.61M 5.06M 7.18M 1.88M -15K -492K 114K -959K -2.19M -1.9M -1.42M -985K -6.4M -7.74M -5.33M -8.86M -5.57M -7.38M
Selling & General & Admin
15.47M 13.3M 9.77M 13.35M 12.63M 12.09M 11.95M 11.88M 13.31M 14.29M 12.18M 12.05M 15.18M 17.19M 15.14M 18.42M 15.36M 15.81M
Research & Development
1.57M 1.26M 1.31M 1.29M 1.32M 2.1M 1.16M 1.24M 1.36M 1.19M 1.28M 1.22M 1.25M 1.08M 1.04M 996K 1M 787K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
17.04M 14.56M 11.09M 14.64M 13.95M 14.19M 13.11M 13.12M 14.67M 15.49M 13.46M 13.27M 16.43M 18.26M 16.18M 19.42M 16.36M 16.6M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5K 10K 8K n/a 15K 12K 19K
Selling & Marketing Expenses
8.21M 8.12M 8.72M 7.04M 6.97M 6.74M 6.52M 6.04M 6.01M 7.87M 6.19M 5.87M 8.02M 8.24M 8.64M 7.22M 6.23M 6.26M
Cost & Expenses
27.93M 25.71M 22.01M 23.98M 23M 22.88M 21.36M 20.64M 22.64M 24.52M 22.44M 20.13M 23.12M 24.99M 23.07M 26.15M 23.25M 22.05M
Income Tax Expense
128K 168K 305K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
79.25M 77.81M 76.94M 93.9M 75.56M 75.23M 72.89M 75.05M 73.03M 74.8M 73.88M 68.34M 68.34M 68.31M 68.3M 68.24M 67.99M 64.16M
Shares Outstanding (Diluted)
86.24M 83.23M 81.68M 77.77M 75.56M 75.23M 75.11M 75.05M 74.97M 74.8M 73.88M 68.34M 68.34M 68.31M 68.3M 68.24M 67.99M 64.16M
EPS (Basic)
0.05 0.07 0.09 0.02 -0.00 -0.01 0.00 -0.01 -0.03 -0.03 -0.02 -0.01 -0.09 -0.11 -0.08 -0.13 -0.08 -0.12
EPS (Diluted)
0.04 0.06 0.09 0.02 -0.00 -0.01 0.00 -0.01 -0.03 -0.03 -0.02 -0.01 -0.09 -0.11 -0.08 -0.13 -0.08 -0.12
EBITDA
3.54M 5.14M 7.47M 1.97M 114K -341K 205K -699K -1.87M -1.53M -3.07M -2.62M -5.96M -7.18M -4.93M -8.43M -5.14M -6.96M
EBIT
3.19M 4.77M 7.11M 1.6M -256K -731K -168K -1.15M -2.32M -1.97M -3.53M -3.06M -6.39M -7.73M -5.32M -8.84M -5.55M -7.36M
Depreciation & Amortization
355K 368K 358K 366K 370K 390K 373K 448K 444K 440K 455K 449K 431K 549K 388K 416K 415K 407K